Barba M, Krasniqi E, Pizzuti L, Mazzotta M, et al. COVID-19 risk in breast cancer patients receiving CDK4/6 inhibitors: literature data and a monocentric experience. Breast J 2021 Mar 6. doi: 10.1111/tbj.14204.
PMID: 33677841